Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01308424 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
A Phase 1 study, sponsored by Beech Tree Labs.
- Completed
- Registry status
- Phase 1
- Development phase
- 171
- Enrollment target
NCT01308424 is a Phase 1 study that has completed, run by Beech Tree Labs. The registered enrollment target is 171 participants.
The verdict
NCT01308424, a Phase 1 study, has completed, sponsored by Beech Tree Labs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 171 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.
Interventions
- DRUG Matching placebo
- DRUG BTL TML HSV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01308424
The ClinicalTrials.gov registry entry for NCT01308424 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beech Tree Labs, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Matching placebo is the first listed.
NCT01308424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01308424 about?
NCT01308424 is a clinical study titled "Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection". The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.
What is the current status of trial NCT01308424?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 171 participants. The study started on 2011-01. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01308424?
The interventions under investigation include: Matching placebo (DRUG), BTL TML HSV (DRUG).
Who is sponsoring clinical trial NCT01308424?
This trial is sponsored by Beech Tree Labs, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.